8Novotnv VM. Prevention and management of plalelet transfusion refractoriness. Vox Sang, 1999,76(1):1-13. 被引量：1
9Faber JC. Worldwide overview of existing haemovigilance systems [J]. Transfus Apher Sei, 2004,31(2): 99-110. 被引量：1
10Tobian AA, King KE, Ness PM. Prevention of febrile nonhemolytic and allergic transfusion reactions with pretranfusion medication:is this evidence based medicine? [J]. Transfusion, 2008, 48(11): 2274-2276. 被引量：1
